{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:35:00Z","timestamp":1794364500356,"version":"4.9.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11154-024-09875-z","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T04:20:50Z","timestamp":1707538850000},"page":"691-705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The changing landscape of acromegaly\u00a0\u2013 an epidemiological perspective"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-4387","authenticated-orcid":false,"given":"Christian","family":"Rosendal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-558X","authenticated-orcid":false,"given":"Mai Christiansen","family":"Arlien-S\u00f8borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7990-3557","authenticated-orcid":false,"given":"Eigil Husted","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-9504","authenticated-orcid":false,"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Larsen","family":"Feltoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3019-6775","authenticated-orcid":false,"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-7580","authenticated-orcid":false,"given":"Olaf M.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-1526","authenticated-orcid":false,"given":"Jens Otto Lunde","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0610-7867","authenticated-orcid":false,"given":"Jakob","family":"Dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"9875_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022;10:804\u201326. https:\/\/doi.org\/10.1016\/S2213-8587(22)00244-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9875_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-16-0117","volume":"175","author":"J Dal","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M, Kristensen L, Laurberg P, Pedersen L, et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol. 2016;175:181\u201390. https:\/\/doi.org\/10.1530\/EJE-16-0117.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS. Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol. 2020;182:523\u201331. https:\/\/doi.org\/10.1530\/EJE-20-0019.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, et al. Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database. Endocr Relat Cancer. 2017;24:505\u201318. https:\/\/doi.org\/10.1530\/ERC-17-0253.","journal-title":"Endocr Relat Cancer"},{"key":"9875_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/S12020-018-1764-4","volume":"63","author":"P Caron","year":"2019","unstructured":"Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, et al. Signs and symptoms of acromegaly at diagnosis: the physician\u2019s and the patient\u2019s perspectives in the ACRO-POLIS study. Endocrine. 2019;63:120\u20139. https:\/\/doi.org\/10.1007\/S12020-018-1764-4.","journal-title":"Endocrine"},{"key":"9875_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/S41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165\u201373. https:\/\/doi.org\/10.1038\/S41431-019-0508-0.","journal-title":"Eur J Hum Genet"},{"key":"9875_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/CEN.14828","volume":"97","author":"C Aagaard","year":"2022","unstructured":"Aagaard C, Christophersen AS, Finnerup S, Rosendal C, Gulisano HA, Ettrup KS, et al. The prevalence of acromegaly is higher than previously reported: Changes over a three-decade period. Clin Endocrinol (Oxf). 2022;97:773\u201382. https:\/\/doi.org\/10.1111\/CEN.14828.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-1064","volume":"176","author":"L Maione","year":"2017","unstructured":"Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, et al. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol. 2017;176:645\u201355. https:\/\/doi.org\/10.1530\/EJE-16-1064.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/J.JOCN.2017.10.086","volume":"48","author":"H Ohno","year":"2018","unstructured":"Ohno H, Yoneoka Y, Jinguji S, Watanabe N, Okada M, Fujii Y. Has acromegaly been diagnosed earlier? J Clin Neurosci. 2018;48:138\u201342. https:\/\/doi.org\/10.1016\/J.JOCN.2017.10.086.","journal-title":"J Clin Neurosci"},{"key":"9875_CR10","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1210\/JCEM.87.8.8658","volume":"87","author":"EV Dimaraki","year":"2002","unstructured":"Dimaraki EV, Jaffe CA, Demott-Friberg R, Chandler WF, Barkan AL. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab. 2002;87:3537\u201342. https:\/\/doi.org\/10.1210\/JCEM.87.8.8658.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR11","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/JC.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:3933\u201351. https:\/\/doi.org\/10.1210\/JC.2014-2700.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR12","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1210\/CLINEM\/DGAA405","volume":"105","author":"J Dal","year":"2020","unstructured":"Dal J, Nielsen EH, Rasmussen UF, Andersen M, Feltoft CL, Vestergaard P, et al. Disease control and gender predict the socioeconomic effects of acromegaly: a nationwide cohort study. J Clin Endocrinol Metab. 2020;105:2975\u201382. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA405.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR13","doi-asserted-by":"publisher","unstructured":"St\u00f6rmann S, Cuny T. The socioeconomic burden of acromegaly. Eur J Endocrinol. 2023;189. https:\/\/doi.org\/10.1093\/ejendo\/lvad097.","DOI":"10.1093\/ejendo\/lvad097"},{"key":"9875_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-18-0255","volume":"179","author":"F Bolfi","year":"2018","unstructured":"Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS. Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol. 2018;179:59\u201371. https:\/\/doi.org\/10.1530\/EJE-18-0255.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR15","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1210\/JC.2017-02457","volume":"103","author":"J Dal","year":"2018","unstructured":"Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C, et al. Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab. 2018;103:2182\u20138. https:\/\/doi.org\/10.1210\/JC.2017-02457.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR16","doi-asserted-by":"publisher","unstructured":"Maione L, Chanson P. National acromegaly registries. Best Pract Res Clin Endocrinol Metab. 2019;33. https:\/\/doi.org\/10.1016\/J.BEEM.2019.02.001.","DOI":"10.1016\/J.BEEM.2019.02.001"},{"key":"9875_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11102-015-0701-2","volume":"19","author":"T Burton","year":"2016","unstructured":"Burton T, Le Nestour E, Neary M, Ludlam WH. Incidence and prevalence of acromegaly in a large US health plan database. Pituitary. 2016;19:262\u20137. https:\/\/doi.org\/10.1007\/s11102-015-0701-2.","journal-title":"Pituitary"},{"key":"9875_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.4158\/EP161397.OR","volume":"22","author":"MS Broder","year":"2016","unstructured":"Broder MS, Chang E, Cherepanov D, Neary MP, Ludlam WH. Incidence and prevalence of acromegaly in the United States: a claims-based analysis. Endocr Pract. 2016;22:1327\u201335. https:\/\/doi.org\/10.4158\/EP161397.OR.","journal-title":"Endocr Pract"},{"key":"9875_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/S40618-018-0928-7","volume":"42","author":"M Caputo","year":"2019","unstructured":"Caputo M, Ucciero A, Mele C, De Marchi L, Magnani C, Cena T, et al. Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region. Italy J Endocrinol Invest. 2019;42:397\u2013402. https:\/\/doi.org\/10.1007\/S40618-018-0928-7.","journal-title":"Italy J Endocrinol Invest"},{"key":"9875_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/EJE-21-0216","volume":"185","author":"S Crisafulli","year":"2021","unstructured":"Crisafulli S, Luxi N, Sultana J, Fontana A, Spagnolo F, Giuffrida G, et al. Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185:251\u201363. https:\/\/doi.org\/10.1530\/EJE-21-0216.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR21","doi-asserted-by":"publisher","first-page":"102856","DOI":"10.1016\/j.arcmed.2023.102856","volume":"54","author":"J Kerbel","year":"2023","unstructured":"Kerbel J, Cano-Zaragoza A, Espinosa-Dorado R, Garc\u00eda De La Torre K-E, Mercado M. Real world data on the epidemiology, diagnosis, and treatment of acromegaly: a registries-based approach. Arch Med Res. 2023;54:102856. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102856.","journal-title":"Arch Med Res"},{"key":"9875_CR22","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.18553\/JMCP.2015.21.12.1106","volume":"21","author":"H Placzek","year":"2015","unstructured":"Placzek H, Xu Y, Mu Y, Begelman SM, Fisher M. Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis. J Manag Care Spec Pharm. 2015;21:1106\u201314. https:\/\/doi.org\/10.18553\/JMCP.2015.21.12.1106.","journal-title":"J Manag Care Spec Pharm"},{"key":"9875_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3346\/JKMS.2021.36.E159","volume":"36","author":"SJ Yun","year":"2021","unstructured":"Yun SJ, Lee JK, Park SY, Chin SO. Descriptive epidemiology and survival analysis of acromegaly in Korea. J Korean Med Sci. 2021;36:1\u201310. https:\/\/doi.org\/10.3346\/JKMS.2021.36.E159.","journal-title":"J Korean Med Sci"},{"key":"9875_CR24","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1210\/clinem\/dgz317","volume":"105","author":"KH Park","year":"2020","unstructured":"Park KH, Lee EJ, Seo GH, Ku CR. Risk for acromegaly-related comorbidities by sex in Korean acromegaly. J Clin Endocrinol Metab. 2020;105:1815\u201326. https:\/\/doi.org\/10.1210\/clinem\/dgz317.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR25","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1159\/000505332","volume":"110","author":"JC Wu","year":"2020","unstructured":"Wu JC, Huang WC, Chang HK, Ko CC, Lirng JF, Chen YC. Natural history of acromegaly: incidences, re-operations, cancers, and mortality rates in a national cohort. Neuroendocrinology. 2020;110:977\u201387. https:\/\/doi.org\/10.1159\/000505332.","journal-title":"Neuroendocrinology"},{"key":"9875_CR26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1507\/ENDOCRJ.EJ20-0129","volume":"67","author":"K Matsubayashi","year":"2020","unstructured":"Matsubayashi K, Kawakami K. Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database. Endocr J. 2020;67:997\u20131006. https:\/\/doi.org\/10.1507\/ENDOCRJ.EJ20-0129.","journal-title":"Endocr J"},{"key":"9875_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/EJE.0.1510439","volume":"151","author":"A Mestr\u00f3n","year":"2004","unstructured":"Mestr\u00f3n A, Webb SM, Astorga R, Benito P, Catal\u00e1 M, Gaztambide S, et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol. 2004;151:439\u201346. https:\/\/doi.org\/10.1530\/EJE.0.1510439.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-07-0358","volume":"157","author":"M Bex","year":"2007","unstructured":"Bex M, Abs R, T\u2019Sjoen G, Mockel J, Velkeniers B, Muermans K, et al. AcroBel\u2013the Belgian registry on acromegaly: a survey of the \u201creal-life\u201d outcome in 418 acromegalic subjects. Eur J Endocrinol. 2007;157:399\u2013409. https:\/\/doi.org\/10.1530\/EJE-07-0358.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-12-0602","volume":"168","author":"C Sch\u00f6fl","year":"2012","unstructured":"Sch\u00f6fl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B, et al. Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol. 2012;168:39\u201347. https:\/\/doi.org\/10.1530\/EJE-12-0602.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","volume":"167","author":"M Arosio","year":"2012","unstructured":"Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol. 2012;167:189\u201398. https:\/\/doi.org\/10.1530\/EJE-12-0084.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/CEN.12207","volume":"79","author":"TA Howlett","year":"2013","unstructured":"Howlett TA, Willis D, Walker G, Wass JAH, Trainer PJ. Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists. Clin Endocrinol (Oxf). 2013;79:689\u201399. https:\/\/doi.org\/10.1111\/CEN.12207.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR32","doi-asserted-by":"publisher","unstructured":"Mercieca C, Gruppetta M, Vassallo J. Epidemiology, treatment trends and outcomes of acromegaly. Eur J Intern Med. 2012;23. https:\/\/doi.org\/10.1016\/J.EJIM.2012.07.010.","DOI":"10.1016\/J.EJIM.2012.07.010"},{"key":"9875_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/S11102-012-0454-0","volume":"16","author":"M Gruppetta","year":"2013","unstructured":"Gruppetta M, Mercieca C, Vassallo J. Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 2013;16:545\u201353. https:\/\/doi.org\/10.1007\/S11102-012-0454-0.","journal-title":"Pituitary"},{"key":"9875_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/S12020-018-1630-4","volume":"61","author":"F Gatto","year":"2018","unstructured":"Gatto F, Trifir\u00f2 G, Lapi F, Cocchiara F, Campana C, Dell\u2019Aquila C, et al. Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database. Endocrine. 2018;61:533\u201341. https:\/\/doi.org\/10.1007\/S12020-018-1630-4.","journal-title":"Endocrine"},{"key":"9875_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/J.1365-2265.2009.03667.X","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010;72:377\u201382. https:\/\/doi.org\/10.1111\/J.1365-2265.2009.03667.X.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR36","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1210\/JC.2016-1937","volume":"101","author":"LA Portocarrero-Ortiz","year":"2016","unstructured":"Portocarrero-Ortiz LA, Vergara-Lopez A, Vidrio-Velazquez M, Uribe-Diaz AM, Garc\u00eda-Dominguez A, Reza-Albarr\u00e1n AA, et al. The Mexican acromegaly registry: Clinical and biochemical characteristics at diagnosis and therapeutic outcomes. J Clin Endocrinol Metab. 2016;101:3997\u20134004. https:\/\/doi.org\/10.1210\/JC.2016-1937.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/J.ENDONU.2016.03.009","volume":"63","author":"EL Gavilanez","year":"2016","unstructured":"Gavilanez EL, Guerrero Franco KG, Zambrano NS, Ch\u00e1vez MN, Estrella CL, Burbano LV, et al. Epidemiology of acromegaly in Ecuador. Endocrinol Nutr. 2016;63:333\u20138. https:\/\/doi.org\/10.1016\/J.ENDONU.2016.03.009.","journal-title":"Endocrinol Nutr"},{"key":"9875_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/S42000-020-00191-0","volume":"19","author":"MH AlMalki","year":"2020","unstructured":"AlMalki MH, Ahmad MM, Buhary BM, Aljawair R, Alyamani A, Alhozali A, et al. Clinical features and therapeutic outcomes of patients with acromegaly in Saudi Arabia: a retrospective analysis. Hormones (Athens). 2020;19:377\u201383. https:\/\/doi.org\/10.1007\/S42000-020-00191-0.","journal-title":"Hormones (Athens)"},{"key":"9875_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/CEN.12020","volume":"78","author":"O Kwon","year":"2013","unstructured":"Kwon O, Song YD, Kim SY, Lee EJ. Nationwide survey of acromegaly in South Korea. Clin Endocrinol (Oxf). 2013;78:577\u201385. https:\/\/doi.org\/10.1111\/CEN.12020.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR40","first-page":"55","volume":"59","author":"CM Ritchie","year":"1990","unstructured":"Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T, et al. Ascertainment and natural history of treated acromegaly in Northern Ireland. Ulster Med J. 1990;59:55\u201362.","journal-title":"Ulster Med J"},{"key":"9875_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/J.1365-2265.1980.TB03135.X","volume":"12","author":"L Alexander","year":"1980","unstructured":"Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf). 1980;12:71\u20139. https:\/\/doi.org\/10.1111\/J.1365-2265.1980.TB03135.X.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03344942","volume":"16","author":"J Etxabe","year":"1993","unstructured":"Etxabe J, Gaztambide S, Latorre P, Vazquez JA. Acromegaly: an epidemiological study. J Endocrinol Invest. 1993;16:181\u20137. https:\/\/doi.org\/10.1007\/BF03344942.","journal-title":"J Endocrinol Invest"},{"key":"9875_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-10-0465","volume":"163","author":"S Cannav\u00f2","year":"2010","unstructured":"Cannav\u00f2 S, Ferra\u00f9 F, Ragonese M, Curt\u00f2 L, Torre ML, Magistri M, et al. Increased prevalence of acromegaly in a highly polluted area. Eur J Endocrinol. 2010;163:509\u201313. https:\/\/doi.org\/10.1530\/EJE-10-0465.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/CJN.2015.301","volume":"43","author":"K Al-Dahmani","year":"2016","unstructured":"Al-Dahmani K, Mohammad S, Imran F, Theriault C, Doucette S, Zwicker D, et al. Sellar masses: an epidemiological study. Can J Neurol Sci. 2016;43:291\u20137. https:\/\/doi.org\/10.1017\/CJN.2015.301.","journal-title":"Can J Neurol Sci"},{"key":"9875_CR45","first-page":"448","volume":"24","author":"A Zaina","year":"2022","unstructured":"Zaina A, Shimon I, Abid A, Arad E, Baron E, Golden E, et al. High prevalence of acromegaly in different industrial areas: a population-based study from Haifa and the Western Galilee District in Northern Israel. Israel Med Assoc J. 2022;24:448\u201353.","journal-title":"Israel Med Assoc J"},{"key":"9875_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5144\/0256-4947.2016.341","volume":"36","author":"KS Aljabri","year":"2016","unstructured":"Aljabri KS, Bokhari SA, Assiri FY, Alshareef MA, Khan PM. The epidemiology of pituitary adenomas in a community-based hospital: a retrospective single center study in Saudi Arabia. Ann Saudi Med. 2016;36:341. https:\/\/doi.org\/10.5144\/0256-4947.2016.341.","journal-title":"Ann Saudi Med"},{"key":"9875_CR47","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1590\/2359-3997000000195","volume":"60","author":"P Fainstein Day","year":"2016","unstructured":"Fainstein Day P, Loto MG, Glerean M, Picasso MFR, Lovazzano S, Giunta DH. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires. Argentina Arch Endocrinol Metab. 2016;60:554\u201361. https:\/\/doi.org\/10.1590\/2359-3997000000195.","journal-title":"Argentina Arch Endocrinol Metab"},{"key":"9875_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/07435809909066141","volume":"25","author":"GTC Ko","year":"1999","unstructured":"Ko GTC, Yeung VTF, Chow CC, Cockram CS. Clinical characteristics of acromegaly in Hong Kong. Endocr Res. 1999;25:195\u2013206. https:\/\/doi.org\/10.1080\/07435809909066141.","journal-title":"Endocr Res"},{"key":"9875_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390. https:\/\/doi.org\/10.2147\/CLEP.S91125.","journal-title":"Clin Epidemiol"},{"key":"9875_CR50","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1210\/JC.2004-1381","volume":"90","author":"R Kauppinen-M\u00e4kelin","year":"2005","unstructured":"Kauppinen-M\u00e4kelin R, Sane T, Reunanen A, V\u00e4lim\u00e4ki MJ, Niskanen L, Markkanen H, et al. A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab. 2005;90:4081\u20136. https:\/\/doi.org\/10.1210\/JC.2004-1381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR51","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1210\/JC.2010-0537","volume":"95","author":"A Raappana","year":"2010","unstructured":"Raappana A, Koivukangas J, Ebeling T, Piril\u00e4 T. Incidence of pituitary adenomas in Northern Finland in 1992\u20132007. J Clin Endocrinol Metab. 2010;95:4268\u201375. https:\/\/doi.org\/10.1210\/JC.2010-0537.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-14-0144","volume":"171","author":"A Tj\u00f6rnstrand","year":"2014","unstructured":"Tj\u00f6rnstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Ros\u00e9n T, et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011. Eur J Endocrinol. 2014;171:519\u201326. https:\/\/doi.org\/10.1530\/EJE-14-0144.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/J.0954-6820.1988.TB15881.X","volume":"223","author":"B Bengtsson","year":"1988","unstructured":"Bengtsson B, Ed\u00e9n S, Ernest I, Od\u00e9n A, Sj\u00f6gren B. Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988;223:327\u201335. https:\/\/doi.org\/10.1111\/J.0954-6820.1988.TB15881.X.","journal-title":"Acta Med Scand"},{"key":"9875_CR54","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1530\/EJE-21-0729","volume":"186","author":"S Arnard\u00f3ttir","year":"2022","unstructured":"Arnard\u00f3ttir S, J\u00e4r\u00e5s J, Burman P, Berinder K, Dahlqvist P, Erfurth EM, et al. Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register. Eur J Endocrinol. 2022;186:329\u201339. https:\/\/doi.org\/10.1530\/EJE-21-0729.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/S40618-023-02217-X","author":"J Rob\u00e8rt","year":"2023","unstructured":"Rob\u00e8rt J, Tsatsaris E, Berinder K, Bonelli L, Burman P, Dahlqvist P, et al. Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register. J Endocrinol Invest. 2023. https:\/\/doi.org\/10.1007\/S40618-023-02217-X.","journal-title":"J Endocrinol Invest"},{"key":"9875_CR56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/CLEP.S63758","volume":"6","author":"J Dal","year":"2014","unstructured":"Dal J, Skou N, Nielsen EH, J\u00f8rgensen JOL, Pedersen L. Acromegaly according to the Danish National Registry of Patients: how valid are ICD diagnoses and how do patterns of registration affect the accuracy of registry data? Clin Epidemiol. 2014;6:295\u20139. https:\/\/doi.org\/10.2147\/CLEP.S63758.","journal-title":"Clin Epidemiol"},{"key":"9875_CR57","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/EJE-15-0189","volume":"173","author":"TT Agustsson","year":"2015","unstructured":"Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, et al. The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol. 2015;173:655\u201364. https:\/\/doi.org\/10.1530\/EJE-15-0189.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/S11102-015-0655-4","volume":"18","author":"GT Hoskuldsdottir","year":"2015","unstructured":"Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA. The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary. 2015;18:803\u20137. https:\/\/doi.org\/10.1007\/S11102-015-0655-4.","journal-title":"Pituitary"},{"key":"9875_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/S12020-022-03275-6","volume":"80","author":"CM Falch","year":"2023","unstructured":"Falch CM, Olarescu NC, Bollerslev J, Dekkers OM, Heck A. Trends in incidence and mortality risk for acromegaly in Norway: a cohort study. Endocrine. 2023;80:152\u20139. https:\/\/doi.org\/10.1007\/S12020-022-03275-6.","journal-title":"Endocrine"},{"key":"9875_CR60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/EJE-14-0249","volume":"171","author":"SL Fougner","year":"2014","unstructured":"Fougner SL, Bollerslev J, Svartberg J, \u00d8ksnes M, Cooper J, Carlsen SM. Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial. Eur J Endocrinol. 2014;171:229\u201335. https:\/\/doi.org\/10.1530\/EJE-14-0249.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR61","doi-asserted-by":"publisher","unstructured":"Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary. 1999 Jun;2(1):29\u201341. https:\/\/doi.org\/10.1023\/a:1009965803750. PMID: 11081170.","DOI":"10.1023\/a:1009965803750"},{"key":"9875_CR62","doi-asserted-by":"publisher","unstructured":"Demir AN, Sulu C, Kara Z, Sahin S, Ozaydin D, Sonmez O, et al. Changing presentation of acromegaly in half a century: a single-center experience. Pituitary. 2023;1\u201310. https:\/\/doi.org\/10.1007\/S11102-023-01344-1\/TABLES\/4.","DOI":"10.1007\/S11102-023-01344-1\/TABLES\/4"},{"key":"9875_CR63","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1055\/S-2006-948313","volume":"114","author":"M Reincke","year":"2006","unstructured":"Reincke M, Petersenn S, Buchfelder M, Gerbert B, Skrobek-Engel G, Franz H, et al. The German Acromegaly Registry: description of the database and initial results. Exp Clin Endocrinol Diabetes. 2006;114:498\u2013505. https:\/\/doi.org\/10.1055\/S-2006-948313.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"9875_CR64","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/EJE-08-0498","volume":"159","author":"S Petersenn","year":"2008","unstructured":"Petersenn S, Buchfelder M, Reincke M, Strasburger CM, Franz H, Lohmann R, et al. Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. Eur J Endocrinol. 2008;159:525\u201332. https:\/\/doi.org\/10.1530\/EJE-08-0498.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR65","doi-asserted-by":"publisher","unstructured":"Mercado M, Abreu C, Vergara-L\u00f3pez A, Gonz\u00e1lez-Virla B, Espinosa-De-los-Monteros AL, Sosa- Eroza E, et al. Surgical and pharmacological outcomes in acromegaly: Real-life data from the Mexican acromegaly registry. J Clin Endocrinol Metab. 2020;105. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA664.","DOI":"10.1210\/CLINEM\/DGAA664"},{"key":"9875_CR66","doi-asserted-by":"publisher","unstructured":"Bolanowski M, Adnan Z, Doknic M, Guk M, H\u00e1na V, Ilovayskaya I, et al. Acromegaly: Clinical care in Central and Eastern Europe, Israel, and Kazakhstan. Front Endocrinol (Lausanne) 2022;13. https:\/\/doi.org\/10.3389\/FENDO.2022.816426.","DOI":"10.3389\/FENDO.2022.816426"},{"key":"9875_CR67","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A, Li D, Kaur RJ, Zhang C, Singh S, Li T, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9875_CR68","doi-asserted-by":"publisher","first-page":"E2251","DOI":"10.1210\/CLINEM\/DGAA965","volume":"106","author":"A Ebbehoj","year":"2021","unstructured":"Ebbehoj A, Stochholm K, Jacobsen SF, Trolle C, Jepsen P, Robaczyk MG, et al. Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study. J Clin Endocrinol Metab. 2021;106:E2251\u201361. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA965.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR69","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/JC.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u0301o E, J\u00f8rgensen JOL, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, et al. Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab. 2013;98:2277\u201384. https:\/\/doi.org\/10.1210\/JC.2012-3582.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR70","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/S11102-017-0813-Y","volume":"20","author":"C Fern\u00e1ndez Mateos","year":"2017","unstructured":"Fern\u00e1ndez Mateos C, Garc\u00eda-Uria M, Morante TL, Garc\u00eda-Ur\u00eda J. Acromegaly: surgical results in 548 patients. Pituitary. 2017;20:522\u20138. https:\/\/doi.org\/10.1007\/S11102-017-0813-Y.","journal-title":"Pituitary"},{"key":"9875_CR71","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/JIM-2020-001605","volume":"69","author":"EA Giraldi","year":"2021","unstructured":"Giraldi EA, Veledar E, Oyesiku NM, Ioachimescu AG. Incidentally detected acromegaly: single-center study of surgically treated patients over 22 years. J Investig Med. 2021;69:351\u20137. https:\/\/doi.org\/10.1136\/JIM-2020-001605.","journal-title":"J Investig Med"},{"key":"9875_CR72","doi-asserted-by":"publisher","first-page":"1266339","DOI":"10.3389\/FENDO.2023.1266339","volume":"14","author":"DR Clemmons","year":"2023","unstructured":"Clemmons DR, Bidlingmaier M. Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly. Front Endocrinol (Lausanne). 2023;14:1266339. https:\/\/doi.org\/10.3389\/FENDO.2023.1266339.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9875_CR73","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1210\/JC.2018-01113","volume":"103","author":"Espinosa De Los","year":"2018","unstructured":"De Los Espinosa, Monteros AL, Sosa-Eroza E, Gonzalez B, Mendoza V, Mercado M. Prevalence, clinical and biochemical spectrum, and treatment outcome of acromegaly with normal basal GH at diagnosis. J Clin Endocrinol Metab. 2018;103:3919\u201324. https:\/\/doi.org\/10.1210\/JC.2018-01113.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR74","doi-asserted-by":"publisher","first-page":"E937","DOI":"10.1210\/CLINEM\/DGZ096","volume":"105","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab. 2020;105:E937\u201346. https:\/\/doi.org\/10.1210\/CLINEM\/DGZ096.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/J.1365-2265.2009.03626.X","volume":"72","author":"TJ Reid","year":"2010","unstructured":"Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf). 2010;72:203\u20138. https:\/\/doi.org\/10.1111\/J.1365-2265.2009.03626.X.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/S12020-020-02206-7","volume":"68","author":"MR Ambrosio","year":"2020","unstructured":"Ambrosio MR, Gagliardi I, Chiloiro S, Ferreira AG, Bondanelli M, Giampietro A, et al. Acromegaly in the elderly patients. Endocrine. 2020;68:16\u201331. https:\/\/doi.org\/10.1007\/S12020-020-02206-7.","journal-title":"Endocrine"},{"key":"9875_CR77","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/CEN.14392","volume":"94","author":"J Dal","year":"2021","unstructured":"Dal J, Skov BG, Andersen M, Feldt-Rasmussen U, Feltoft CL, Karmisholt J, et al. Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature. Clin Endocrinol (Oxf). 2021;94:625\u201335. https:\/\/doi.org\/10.1111\/CEN.14392.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/CEN.12112","volume":"79","author":"S Vallette","year":"2013","unstructured":"Vallette S, Ezzat S, Chik C, Ur E, Imran SA, Van Uum S, et al. Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol (Oxf). 2013;79:79\u201385. https:\/\/doi.org\/10.1111\/CEN.12112.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/J.1365-2265.1987.TB00805.X","volume":"26","author":"JDN Nabarro","year":"1987","unstructured":"Nabarro JDN. Acromegaly. Clin Endocrinol (Oxf). 1987;26:481\u2013512. https:\/\/doi.org\/10.1111\/J.1365-2265.1987.TB00805.X.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR80","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1210\/JC.2007-2149","volume":"93","author":"L Nachtigall","year":"2008","unstructured":"Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A. Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab. 2008;93:2035\u201341. https:\/\/doi.org\/10.1210\/JC.2007-2149.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR81","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/S11102-015-0702-1","volume":"19","author":"I Kreitschmann-Andermahr","year":"2016","unstructured":"Kreitschmann-Andermahr I, Siegel S, Kleist B, Kohlmann J, Starz D, Buslei R, et al. Diagnosis and management of acromegaly: the patient\u2019s perspective. Pituitary. 2016;19:268\u201376. https:\/\/doi.org\/10.1007\/S11102-015-0702-1.","journal-title":"Pituitary"},{"key":"9875_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/CEN.14750","author":"J Dal","year":"2022","unstructured":"Dal J, Rosendal C, Karmisholt J, Feldt-Rasmussen U, Andersen MS, Klose M, et al. Sex difference in patients with controlled acromegaly\u2014A multicentre survey. Clin Endocrinol (Oxf). 2022. https:\/\/doi.org\/10.1111\/CEN.14750.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9875_CR83","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/EJE-19-1023","volume":"182","author":"NF Lenders","year":"2020","unstructured":"Lenders NF, McCormack AI, Ho KKY. MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly? Eur J Endocrinol. 2020;182:R67-82. https:\/\/doi.org\/10.1530\/EJE-19-1023.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR84","doi-asserted-by":"publisher","unstructured":"Ciresi A, Amato MC, Pivonello R, Nazzari E, Grasso LF, Minuto F, et al. The metabolic profile in active acromegaly is gender-specific. J Clin Endocrinol Metab. 2013;98. https:\/\/doi.org\/10.1210\/JC.2012-2896.","DOI":"10.1210\/JC.2012-2896"},{"key":"9875_CR85","unstructured":"Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med. 1970 Jan;39(153):1-16. PMID:\u00a05427331."},{"key":"9875_CR86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/JC.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008;93:61\u20137. https:\/\/doi.org\/10.1210\/JC.2007-1191.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol. 2008;159:89\u201395. https:\/\/doi.org\/10.1530\/EJE-08-0267.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR88","doi-asserted-by":"publisher","unstructured":"Kim J, Hong N, Choi J, Hyung Moon J, Hyun Kim E, Won Hong J, et al. Sex differences in mortality in patients with acromegaly: a nationwide cohort study in Korea. Eur J Endocrinol. 2023;189. https:\/\/doi.org\/10.1093\/ejendo\/lvad106.","DOI":"10.1093\/ejendo\/lvad106"},{"key":"9875_CR89","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1530\/EJE-18-0015","volume":"178","author":"D Esposito","year":"2018","unstructured":"Esposito D, Ragnarsson O, Granfeldt D, Marlow T, Johannsson G, Olsson DS. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur J Endocrinol. 2018;178:459\u201369. https:\/\/doi.org\/10.1530\/EJE-18-0015.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR90","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1210\/CLINEM\/DGAD141","volume":"108","author":"B Biagetti","year":"2023","unstructured":"Biagetti B, Iglesias P, Villar-Taibo R, Moure MD, Paja M, Araujo-Castro M, et al. Mortality in acromegaly diagnosed in older individuals in Spain is higher in women compared to the general spanish population. J Clin Endocrinol Metab. 2023;108:2193\u2013202. https:\/\/doi.org\/10.1210\/CLINEM\/DGAD141.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR91","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-19-0794","volume":"182","author":"NA Tritos","year":"2020","unstructured":"Tritos NA, Mattsson AF, Vila G, Biller BMK, Klibanski A, Valluri S, et al. All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis. Eur J Endocrinol. 2020;182:285\u201392. https:\/\/doi.org\/10.1530\/EJE-19-0794.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR92","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/S11102-015-0700-3","volume":"19","author":"L Varadhan","year":"2016","unstructured":"Varadhan L, Reulen RC, Brown M, Clayton RN. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study. Pituitary. 2016;19:251\u201361. https:\/\/doi.org\/10.1007\/S11102-015-0700-3.","journal-title":"Pituitary"},{"key":"9875_CR93","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/ERC-16-0106","volume":"23","author":"E Ritvonen","year":"2016","unstructured":"Ritvonen E, L\u00f6yttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P, et al. Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer. 2016;23:469\u201380. https:\/\/doi.org\/10.1530\/ERC-16-0106.","journal-title":"Endocr Relat Cancer"},{"key":"9875_CR94","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/EJE-13-1022","volume":"171","author":"A Colao","year":"2014","unstructured":"Colao A, Vandeva S, Pivonello R, Grasso LFS, Nachev E, Auriemma RS, et al. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy). Eur J Endocrinol. 2014;171:263\u201373. https:\/\/doi.org\/10.1530\/EJE-13-1022.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR95","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1210\/JC.2014-2670","volume":"99","author":"M Mercado","year":"2014","unstructured":"Mercado M, Gonzalez B, Vargas G, Ramirez C, De Los Espinosa, Monteros AL, Sosa E, et al. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab. 2014;99:4438\u201346. https:\/\/doi.org\/10.1210\/JC.2014-2670.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR96","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-13-0166","volume":"169","author":"F Bogazzi","year":"2013","unstructured":"Bogazzi F, Colao A, Rossi G, Lombardi M, Urbani C, Sardella C, et al. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur J Endocrinol. 2013;169:367\u201376. https:\/\/doi.org\/10.1530\/EJE-13-0166.","journal-title":"Eur J Endocrinol"},{"key":"9875_CR97","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1210\/JC.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab. 2009;94:4216\u201323. https:\/\/doi.org\/10.1210\/JC.2009-1097.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR98","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/J.GHIR.2010.09.003","volume":"20","author":"TE Wu","year":"2010","unstructured":"Wu TE, Da LH, Lu RA, Wang ML, Chen RL, Chen HS. The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery. Growth Horm IGF Res. 2010;20:411\u20135. https:\/\/doi.org\/10.1016\/J.GHIR.2010.09.003.","journal-title":"Growth Horm IGF Res"},{"key":"9875_CR99","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1210\/JC.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab. 2004;89:667\u201374. https:\/\/doi.org\/10.1210\/JC.2003-031199.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR100","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1210\/JCEM.83.8.5007","volume":"83","author":"SM Orme","year":"1998","unstructured":"Orme SM, McNally RJQ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab. 1998;83:2730\u20134. https:\/\/doi.org\/10.1210\/JCEM.83.8.5007.","journal-title":"J Clin Endocrinol Metab"},{"key":"9875_CR101","doi-asserted-by":"publisher","unstructured":"Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J; Preoperative Octreotide Treatment of Acromegaly study group. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab. 2008 Aug;93(8):2984\u201390. https:\/\/doi.org\/10.1210\/jc.2008-0315. Epub 2008 May 20. PMID: 18492760","DOI":"10.1210\/jc.2008-0315"},{"key":"9875_CR102","doi-asserted-by":"publisher","unstructured":"Almalki MH, Chesover AD, Johnson MD, Wilkins GE, Maguire JA, Ur E. Characterization of management and outcomes of patients with acromegaly in Vancouver over 30 years. Clin Invest Med. 2012 Feb 1;35(1):E27\u201333. https:\/\/doi.org\/10.25011\/cim.v35i1.16103. PMID: 22309962.","DOI":"10.25011\/cim.v35i1.16103"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09875-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-024-09875-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09875-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:32:17Z","timestamp":1722493937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-024-09875-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["9875"],"URL":"https:\/\/doi.org\/10.1007\/s11154-024-09875-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"12 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JD: Unrestricted research grant from Pfizer and Ipsen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}